Fortress Biotech, Inc. SEC filings FBIO

Fortress Biotech, Inc. has 886 filings in SEC EDGAR's recent list, going back to Mar 5, 2008. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.

Fortress Biotech, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 29, 2026 —
8-K Current report
Other events
Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Oct 1, 2026
SCHEDULE 13G Ownership over 5% (passive) Sep 1, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
8-K Current report
Shareholder vote results
Jun 23, 2026 Jun 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 17, 2026
4 Insider transaction Apr 1, 2026 Apr 1, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
8-K Current report
Other events
Mar 30, 2026 Mar 30, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 20, 2026 —
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
8-K Current report
Material agreement, New debt, Other events
Feb 23, 2026 Feb 22, 2026
8-K Current report
Other events
Jan 13, 2026 Jan 13, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 6, 2026 —
4 Insider transaction Jan 6, 2026 Jan 2, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 5, 2026 —
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
424B3 Prospectus Dec 18, 2025 —
EFFECT Filing Dec 17, 2025 —
CORRESP Letter to the SEC Dec 16, 2025 —
S-1 Registration statement Dec 16, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 15, 2025 Dec 12, 2025
8-K Current report
Other events
Dec 15, 2025 Dec 15, 2025
8-K Current report
Other events
Nov 17, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
4 Insider transaction Oct 2, 2025 Oct 1, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 1, 2025 —
4 Insider transaction Oct 1, 2025 Sep 29, 2025
8-K Current report
Other events
Oct 1, 2025 Oct 1, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
424B7 Filing Aug 1, 2025 —
8-K Current report
Other events
Jul 16, 2025 Jul 16, 2025
8-K Current report
Shareholder vote results
Jun 23, 2025 Jun 17, 2025
8-K Current report
Acquisition or sale of assets
Jun 5, 2025 May 30, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 3, 2025 —
4 Insider transaction Jun 3, 2025 May 29, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 17, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 17, 2025
8-K Current report
Officer or director change
Apr 16, 2025 Apr 15, 2025
EFFECT Filing Apr 2, 2025 —
EFFECT Filing Apr 2, 2025 —
EFFECT Filing Apr 2, 2025 —
EFFECT Filing Apr 2, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 2, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 2, 2025 —
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 1, 2025 Apr 1, 2025
POS AM Filing Apr 1, 2025 —
POS AM Filing Apr 1, 2025 —
POS AM Filing Apr 1, 2025 —
POS AM Filing Apr 1, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 11, 2025 —
8-K Current report
Material agreement
Mar 10, 2025 Mar 9, 2025
4 Insider transaction Feb 27, 2025 Feb 26, 2025
8-K Current report
Other events
Jan 16, 2025 Jan 16, 2025
8-K Current report
Other events
Jan 6, 2025 Jan 6, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 3, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 3, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 3, 2025 —
4 Insider transaction Jan 3, 2025 Jan 1, 2025
3 Initial insider ownership Jan 3, 2025 Dec 31, 2024
3 Initial insider ownership Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Dec 23, 2024 Dec 19, 2024
8-K Current report
Other events
Dec 16, 2024 Dec 13, 2024
SC 13D/A Amended ownership over 5% (active) Nov 15, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Other events
Nov 4, 2024 Nov 4, 2024
424B3 Prospectus Oct 25, 2024 —
SC 13G Ownership over 5% (passive) Oct 25, 2024 —
EFFECT Filing Oct 7, 2024 —
424B3 Prospectus Oct 7, 2024 —
CORRESP Letter to the SEC Oct 2, 2024 —
UPLOAD Letter from the SEC Oct 2, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 1, 2024 —
4 Insider transaction Oct 1, 2024 Oct 1, 2024
4 Insider transaction Oct 1, 2024 Sep 27, 2024
S-1 Registration statement Sep 27, 2024 —
SC 13D/A Amended ownership over 5% (active) Sep 25, 2024 —
4 Insider transaction Sep 25, 2024 Sep 23, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 23, 2024 Sep 19, 2024
424B5 Prospectus supplement Sep 23, 2024 —
424B5 Prospectus supplement Sep 20, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
424B5 Prospectus supplement Aug 2, 2024 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Jul 25, 2024 Jul 25, 2024
8-K Current report
Material agreement
Jul 19, 2024 Jul 15, 2024
4 Insider transaction Jul 15, 2024 Jul 11, 2024
4 Insider transaction Jul 12, 2024 Jul 10, 2024
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jul 10, 2024 Jul 8, 2024
8-K Current report
Other events
Jul 5, 2024 Jul 5, 2024
4 Insider transaction Jul 1, 2024 Jun 28, 2024
8-K Current report
Unregistered share sale
Jun 28, 2024 Jun 27, 2024
SC 13D/A Amended ownership over 5% (active) Jun 28, 2024 —
4 Insider transaction Jun 28, 2024 Jun 27, 2024
EFFECT Filing Jun 27, 2024 —
424B3 Prospectus Jun 27, 2024 —
8-K Current report
Bylaw or fiscal year change
Jun 25, 2024 Jun 19, 2024
CORRESP Letter to the SEC Jun 25, 2024 —
UPLOAD Letter from the SEC Jun 24, 2024 —
S-3 Shelf registration Jun 20, 2024 —
4 Insider transaction May 31, 2024 May 12, 2022
3 Initial insider ownership May 31, 2024 Nov 16, 2021
S-8 Employee stock plan registration May 31, 2024 —
S-8 Employee stock plan registration May 31, 2024 —
424B5 Prospectus supplement May 31, 2024 —
EFFECT Filing May 30, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2024 May 23, 2024
CORRESP Letter to the SEC May 29, 2024 —
S-3/A Form s-3/a May 29, 2024 —
UPLOAD Letter from the SEC May 24, 2024 —
3 Initial insider ownership May 24, 2024 May 16, 2024
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 20, 2024 May 20, 2024
SC 13D/A Amended ownership over 5% (active) May 17, 2024 —
S-3 Shelf registration May 17, 2024 —
144 Notice of proposed sale May 17, 2024 —
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
SC 13D/A Amended ownership over 5% (active) Apr 17, 2024 —
4 Insider transaction Apr 17, 2024 Apr 16, 2024
DEFA14A Additional proxy material Apr 5, 2024 —
DEF 14A Proxy statement Apr 5, 2024 May 23, 2024
424B3 Prospectus Apr 5, 2024 —
4 Insider transaction Apr 2, 2024 Apr 1, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
SC 13D/A Amended ownership over 5% (active) Mar 22, 2024 —
4 Insider transaction Mar 22, 2024 Mar 20, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
8-K Current report
Officer or director change
Jan 26, 2024 Jan 25, 2024
4 Insider transaction Jan 9, 2024 Jan 5, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
SC 13D/A Amended ownership over 5% (active) Jan 3, 2024 —
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Jan 3, 2024 Dec 29, 2023
4 Insider transaction Jan 3, 2024 Jan 2, 2024
8-K Current report
Material agreement, Other events
Jan 3, 2024 Dec 29, 2023
424B5 Prospectus supplement Jan 3, 2024 —
4 Insider transaction Dec 22, 2023 Dec 20, 2023
UPLOAD Letter from the SEC Nov 30, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 21, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 21, 2023 —
4 Insider transaction Nov 16, 2023 Nov 14, 2023
4 Insider transaction Nov 16, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Material agreement, Other events
Nov 14, 2023 Nov 9, 2023
424B5 Prospectus supplement Nov 13, 2023 —
424B5 Prospectus supplement Nov 9, 2023 —
CORRESP Letter to the SEC Oct 26, 2023 —
8-K Current report
Other events
Oct 26, 2023 Oct 24, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Oct 10, 2023 Oct 9, 2023
S-8 Employee stock plan registration Sep 29, 2023 —
S-8 Employee stock plan registration Sep 29, 2023 —
UPLOAD Letter from the SEC Sep 27, 2023 —
4 Insider transaction Sep 27, 2023 Sep 26, 2023
SC 13D/A Amended ownership over 5% (active) Sep 26, 2023 —
4 Insider transaction Sep 26, 2023 Sep 25, 2023
SC 13D/A Amended ownership over 5% (active) Sep 18, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
FBIO (Nasdaq), FBIOP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bay Harbor Islands, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1429260
Former names
Fortress Biotech, Inc. (until Oct 29, 2026); CORONADO BIOSCIENCES INC (until Apr 27, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.